📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Below are the financial statements of SK Biopharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
Below are the financial statements of SK Biopharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in trillions of KRW | 2024 | 2023 |
|---|---|---|
| Revenue | 0.55a | 0.35a |
| XCOPRI US | 0.44a | 0.27a |
| DP/API | 0.03a | 0.01a |
| Service revenue | 0.08a | 0.07a |
| Gross profit | 0.5a | 0.32a |
| SG&A expense | -0.41a | -0.36a |
| Operating profit | 0.1a | -0.04a |
| Profit before income tax | 0.07a | -0.04a |
| Net profit | 0.23a | -0.04a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SK Biopharmaceuticals’s data sources below and access millions more through our Disclosure Search.